Acepodia is a privately held biotechnology company focused on developing innovative, highly effective cell therapies to treat cancers. The company was spun-off from Professor Carolyn Bertozzi's lab and was founded in 2017 by Dr. Patrick Y. Yang and Dr. Sonny Hsiao.

Acepodia, Inc. operates as a clinical stage biotechnology company. The company engages in developing cell therapies with its unique antibody cell conjugation (ACC) platform technology to address gaps in cancer care. It links tumor targeting antibodies to its proprietary immune cells, such as gamma delta 2 T cells to create novel ACE therapies. The company was founded in 2017 and is headquartered in Grand Cayman, the Cayman Islands.

6976

COM:ACEPODIA

Acepodia

Last Close

18.05

25/11 06:59

Market Cap

13.86B

Beta: -

Volume Today

673.76K

Avg: -

Analysis Not Available